OOIR: Observatory of International Research

Papers

(The H4-Index of Current Neuropharmacology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Effects of β -caryophyllene, A Dietary Cannabinoid, in Animal Models of Drug Addiction	133
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder	112
Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease	103
Modulating Ferroptosis: A Novel Approach to Promote Neural Repair in Brain Injury	101
Childhood Trauma and Self-harm in Youths with Bipolar Disorders	95
Local and Remote Chemogenetic Suppression of Hippocampal Seizures in Rats	91
Neurobiological Mechanisms Underlying Hippocampal Dysfunction in Post-Traumatic Stress Disorder	89
Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson’s Disease: An Update Since 2017	86
Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management	70
Redox Modulation of Meniere Disease by Coriolus versicolor Treatment, a Nutritional Mushroom Approach with Neuroprotective Potential	69
Neurocognitive Correlates of Cerebellar Volumetric Alterations in Youth with Pediatric Bipolar Spectrum Disorders and Bipolar Offspring	67
Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS	65
Role of Glycerophospholipid Metabolism in Epilepsy	63
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study	62
Gut Microbiota, Plasma Metabolites, and Synucleinopathies: A Mendelian Randomization Study	62
GLP-1 Receptor Agonists in Neuropathic Pain and Neurodegenerative Diseases: Mechanisms, Therapeutic Potentials, and Future Perspectives	61
Early Family Intervention for Youth at Risk for Bipolar Disorder: Psychosocial and Neural Mediators of Outcome	61
Meet the Editorial Board Member	58
Thematic Selection: Stress and Stress-related Disorders Neurobiology & Translational Aspects of Stress-related Disorders (Part 3)	58
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy	57
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases	55
Linking Diabetes to Alzheimer’s Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase	53
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation	51
Unraveling the Role of Perivascular Macrophages in Alzheimer's Disease: Insights from the Crosstalk between Immunometabolism and Ferroptosis	51
Role of Traditional Chinese Medicine Formulations in Reducing Neuroinflammation and Oxidative Stress in Alzheimer’s Disease	49

Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis	48
Unveiling the Potential Neuroprotective Effect of Bioactive Compounds from Plants with Sedative and Mood-Modulating Properties: Innovative Approaches for the Prevention of Alzheimer's and Parkinson's	47
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development	47
Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain	43
Myeloid-derived Suppressor Cells and Multiple Sclerosis	40
Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials	40
Antioxidants, Hormetic Nutrition, and Autism	39
Recent Advances in Guillain-Barré Syndrome: Neurological Disorder, Pathophysiology, Diagnosis, Treatment, and Challenges	38
CREB-Mediated Regulation of Microglial Polarization in Central Nervous System Diseases	38
Targeting the Kynurenine Pathway to Improve Mood Disorders	38
OL-FS13 Alleviates Cerebral Ischemia-reperfusion Injury by Inhibiting miR-21-3p Expression	37
Repetitive Transcranial Magnetic Stimulation Alters Brain Communication Networks to Improve the Cognitive Function in Patients with Amnestic Mild Cognitive Impairment - A Clinical Trial	36
Brivaracetam in Refractory Epilepsy: Mechanism, Tolerability, and Clinical Positioning	36
Sex-Specific Association between Antioxidant Defense System and Therapeutic Response to Risperidone in Schizophrenia: A Prospective Longitudinal Study	36